URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer cocktail: new combo aims to tame tough tumors
Disease control OngoingThis early-phase trial tests a combination of three drugs—bortezomib, gemcitabine, and doxorubicin—in people with advanced urothelial cancer or other solid tumors that cannot be removed by surgery. The main goal is to find the highest safe dose of the two chemotherapy drugs when …
Matched conditions: URETHRAL CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Chemo cocktail takes on rare bladder cancers
Disease control OngoingThis phase 2 trial tested a combination of four chemotherapy drugs (5-FU, leucovorin, gemcitabine, and cisplatin) in 46 people with advanced or inoperable adenocarcinoma of the bladder, urethra, or urachus. The goal was to see how many patients' tumors shrank or disappeared. Rese…
Matched conditions: URETHRAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC
-
Scientists dig into tumor DNA to crack immunotherapy resistance
Knowledge-focused OngoingThis study examines stored tumor samples from 15 people with kidney or bladder cancer who initially responded to immune checkpoint therapy but later developed new tumors. Researchers will compare the genetic and tissue features of the original and new tumors to understand how the…
Matched conditions: URETHRAL CANCER
Sponsor: Fox Chase Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC